Selected research
Market Analysis & Forecast
Global Helicobacter Pylori Antigen Test Market Analysis and Forecast 2026-2032
Market perspective
The global Helicobacter Pylori Antigen Test market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Helicobacter Pylori Antigen Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Helicobacter Pylori Antigen Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Helicobacter Pylori Antigen Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Helicobacter Pylori Antigen Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Helicobacter Pylori Antigen Test include Abbott Laboratories, Thermo Fisher Scientific, CerTest Biotec, GUANGZHOU WONDFO BIOTECH CO.,LTD, Getein Biotech,Inc, Zhejiang Orient Gene Biotech Co.,Ltd., Denka Company Limited, ACON Laboratories Inc and Coris Bioconcept SRL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Helicobacter Pylori Antigen Test, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Helicobacter Pylori Antigen Test, also provides the revenue of main regions and countries. Of the upcoming market potential for Helicobacter Pylori Antigen Test, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Helicobacter Pylori Antigen Test revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Helicobacter Pylori Antigen Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Helicobacter Pylori Antigen Test revenue, projected growth trends, production technology, application and end-user industry.
Helicobacter Pylori Antigen Test Segment by Company
Abbott Laboratories
Thermo Fisher Scientific
CerTest Biotec
GUANGZHOU WONDFO BIOTECH CO.,LTD
Getein Biotech,Inc
Zhejiang Orient Gene Biotech Co.,Ltd.
Denka Company Limited
ACON Laboratories Inc
Coris Bioconcept SRL
Biosynex SA
CTK Biotech, Inc.
Humasis Co., Ltd.
Assure Tech(HangZhou) Co., Ltd.
Hangzhou Biotest Biotech Co.,Ltd.
Xiamen Boson Biotech
MP Biomedicals
Diagnostic Automation
DRG Diagnostics
Epitope Diagnostics
SD Biosensor
DiaSorin
QuidelOrtho
Helicobacter Pylori Antigen Test Segment by Type
Carbon-13 Breath Test
Carbon-14 Breath Test
Helicobacter Pylori Antigen Test Segment by Application
Medical and Health
Public Health
Medical Examination Services
Other
Helicobacter Pylori Antigen Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Antigen Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Antigen Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Antigen Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Helicobacter Pylori Antigen Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Helicobacter Pylori Antigen Test company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Helicobacter Pylori Antigen Test revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Carbon-13 Breath Test
- Carbon-14 Breath Test
Applications
- Medical and Health
- Public Health
- Medical Examination Services
- Other
Companies covered
- Abbott Laboratories
- Thermo Fisher Scientific
- CerTest Biotec
- GUANGZHOU WONDFO BIOTECH CO.,LTD
- Getein Biotech,Inc
- Zhejiang Orient Gene Biotech Co.,Ltd.
- Denka Company Limited
- ACON Laboratories Inc
- Coris Bioconcept SRL
- Biosynex SA
- CTK Biotech, Inc.
- Humasis Co., Ltd.
- Assure Tech(HangZhou) Co., Ltd.
- Hangzhou Biotest Biotech Co.,Ltd.
- Xiamen Boson Biotech
- MP Biomedicals
- Diagnostic Automation
- DRG Diagnostics
- Epitope Diagnostics
- SD Biosensor
- DiaSorin
- QuidelOrtho
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Helicobacter Pylori Antigen Test Market by Type
- 1.2.1 Global Helicobacter Pylori Antigen Test Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Carbon-13 Breath Test
- 1.2.3 Carbon-14 Breath Test
- 1.3 Helicobacter Pylori Antigen Test Market by Application
- 1.3.1 Global Helicobacter Pylori Antigen Test Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical and Health
- 1.3.3 Public Health
- 1.3.4 Medical Examination Services
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Helicobacter Pylori Antigen Test Market Dynamics
- 2.1 Helicobacter Pylori Antigen Test Industry Trends
- 2.2 Helicobacter Pylori Antigen Test Industry Drivers
- 2.3 Helicobacter Pylori Antigen Test Industry Opportunities and Challenges
- 2.4 Helicobacter Pylori Antigen Test Industry Restraints
3 Global Growth Perspective
- 3.1 Global Helicobacter Pylori Antigen Test Market Perspective (2021-2032)
- 3.2 Global Helicobacter Pylori Antigen Test Growth Trends by Region
- 3.2.1 Global Helicobacter Pylori Antigen Test Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Helicobacter Pylori Antigen Test Market Size by Region (2021-2026)
- 3.2.3 Global Helicobacter Pylori Antigen Test Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Helicobacter Pylori Antigen Test Revenue by Players
- 4.1.1 Global Helicobacter Pylori Antigen Test Revenue by Players (2021-2026)
- 4.1.2 Global Helicobacter Pylori Antigen Test Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Helicobacter Pylori Antigen Test Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Helicobacter Pylori Antigen Test Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Helicobacter Pylori Antigen Test Key Players Headquarters & Area Served
- 4.4 Global Helicobacter Pylori Antigen Test Players, Product Type & Application
- 4.5 Global Helicobacter Pylori Antigen Test Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Helicobacter Pylori Antigen Test Market CR5 and HHI
- 4.6.3 2025 Helicobacter Pylori Antigen Test Tier 1, Tier 2, and Tier 3
5 Helicobacter Pylori Antigen Test Market Size by Type
- 5.1 Global Helicobacter Pylori Antigen Test Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Helicobacter Pylori Antigen Test Revenue by Type (2021-2032)
- 5.3 Global Helicobacter Pylori Antigen Test Revenue Market Share by Type (2021-2032)
6 Helicobacter Pylori Antigen Test Market Size by Application
- 6.1 Global Helicobacter Pylori Antigen Test Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Helicobacter Pylori Antigen Test Revenue by Application (2021-2032)
- 6.3 Global Helicobacter Pylori Antigen Test Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Abbott Laboratories
- 7.1.1 Abbott Laboratories Company Information
- 7.1.2 Abbott Laboratories Business Overview
- 7.1.3 Abbott Laboratories Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.1.4 Abbott Laboratories Helicobacter Pylori Antigen Test Product Portfolio
- 7.1.5 Abbott Laboratories Recent Developments
- 7.2 Thermo Fisher Scientific
- 7.2.1 Thermo Fisher Scientific Company Information
- 7.2.2 Thermo Fisher Scientific Business Overview
- 7.2.3 Thermo Fisher Scientific Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.2.4 Thermo Fisher Scientific Helicobacter Pylori Antigen Test Product Portfolio
- 7.2.5 Thermo Fisher Scientific Recent Developments
- 7.3 CerTest Biotec
- 7.3.1 CerTest Biotec Company Information
- 7.3.2 CerTest Biotec Business Overview
- 7.3.3 CerTest Biotec Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.3.4 CerTest Biotec Helicobacter Pylori Antigen Test Product Portfolio
- 7.3.5 CerTest Biotec Recent Developments
- 7.4 GUANGZHOU WONDFO BIOTECH CO.,LTD
- 7.4.1 GUANGZHOU WONDFO BIOTECH CO.,LTD Company Information
- 7.4.2 GUANGZHOU WONDFO BIOTECH CO.,LTD Business Overview
- 7.4.3 GUANGZHOU WONDFO BIOTECH CO.,LTD Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.4.4 GUANGZHOU WONDFO BIOTECH CO.,LTD Helicobacter Pylori Antigen Test Product Portfolio
- 7.4.5 GUANGZHOU WONDFO BIOTECH CO.,LTD Recent Developments
- 7.5 Getein Biotech,Inc
- 7.5.1 Getein Biotech,Inc Company Information
- 7.5.2 Getein Biotech,Inc Business Overview
- 7.5.3 Getein Biotech,Inc Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.5.4 Getein Biotech,Inc Helicobacter Pylori Antigen Test Product Portfolio
- 7.5.5 Getein Biotech,Inc Recent Developments
- 7.6 Zhejiang Orient Gene Biotech Co.,Ltd.
- 7.6.1 Zhejiang Orient Gene Biotech Co.,Ltd. Company Information
- 7.6.2 Zhejiang Orient Gene Biotech Co.,Ltd. Business Overview
- 7.6.3 Zhejiang Orient Gene Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.6.4 Zhejiang Orient Gene Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Product Portfolio
- 7.6.5 Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments
- 7.7 Denka Company Limited
- 7.7.1 Denka Company Limited Company Information
- 7.7.2 Denka Company Limited Business Overview
- 7.7.3 Denka Company Limited Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.7.4 Denka Company Limited Helicobacter Pylori Antigen Test Product Portfolio
- 7.7.5 Denka Company Limited Recent Developments
- 7.8 ACON Laboratories Inc
- 7.8.1 ACON Laboratories Inc Company Information
- 7.8.2 ACON Laboratories Inc Business Overview
- 7.8.3 ACON Laboratories Inc Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.8.4 ACON Laboratories Inc Helicobacter Pylori Antigen Test Product Portfolio
- 7.8.5 ACON Laboratories Inc Recent Developments
- 7.9 Coris Bioconcept SRL
- 7.9.1 Coris Bioconcept SRL Company Information
- 7.9.2 Coris Bioconcept SRL Business Overview
- 7.9.3 Coris Bioconcept SRL Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.9.4 Coris Bioconcept SRL Helicobacter Pylori Antigen Test Product Portfolio
- 7.9.5 Coris Bioconcept SRL Recent Developments
- 7.10 Biosynex SA
- 7.10.1 Biosynex SA Company Information
- 7.10.2 Biosynex SA Business Overview
- 7.10.3 Biosynex SA Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.10.4 Biosynex SA Helicobacter Pylori Antigen Test Product Portfolio
- 7.10.5 Biosynex SA Recent Developments
- 7.11 CTK Biotech, Inc.
- 7.11.1 CTK Biotech, Inc. Company Information
- 7.11.2 CTK Biotech, Inc. Business Overview
- 7.11.3 CTK Biotech, Inc. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.11.4 CTK Biotech, Inc. Helicobacter Pylori Antigen Test Product Portfolio
- 7.11.5 CTK Biotech, Inc. Recent Developments
- 7.12 Humasis Co., Ltd.
- 7.12.1 Humasis Co., Ltd. Company Information
- 7.12.2 Humasis Co., Ltd. Business Overview
- 7.12.3 Humasis Co., Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.12.4 Humasis Co., Ltd. Helicobacter Pylori Antigen Test Product Portfolio
- 7.12.5 Humasis Co., Ltd. Recent Developments
- 7.13 Assure Tech(HangZhou) Co., Ltd.
- 7.13.1 Assure Tech(HangZhou) Co., Ltd. Company Information
- 7.13.2 Assure Tech(HangZhou) Co., Ltd. Business Overview
- 7.13.3 Assure Tech(HangZhou) Co., Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.13.4 Assure Tech(HangZhou) Co., Ltd. Helicobacter Pylori Antigen Test Product Portfolio
- 7.13.5 Assure Tech(HangZhou) Co., Ltd. Recent Developments
- 7.14 Hangzhou Biotest Biotech Co.,Ltd.
- 7.14.1 Hangzhou Biotest Biotech Co.,Ltd. Company Information
- 7.14.2 Hangzhou Biotest Biotech Co.,Ltd. Business Overview
- 7.14.3 Hangzhou Biotest Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.14.4 Hangzhou Biotest Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Product Portfolio
- 7.14.5 Hangzhou Biotest Biotech Co.,Ltd. Recent Developments
- 7.15 Xiamen Boson Biotech
- 7.15.1 Xiamen Boson Biotech Company Information
- 7.15.2 Xiamen Boson Biotech Business Overview
- 7.15.3 Xiamen Boson Biotech Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.15.4 Xiamen Boson Biotech Helicobacter Pylori Antigen Test Product Portfolio
- 7.15.5 Xiamen Boson Biotech Recent Developments
- 7.16 MP Biomedicals
- 7.16.1 MP Biomedicals Company Information
- 7.16.2 MP Biomedicals Business Overview
- 7.16.3 MP Biomedicals Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.16.4 MP Biomedicals Helicobacter Pylori Antigen Test Product Portfolio
- 7.16.5 MP Biomedicals Recent Developments
- 7.17 Diagnostic Automation
- 7.17.1 Diagnostic Automation Company Information
- 7.17.2 Diagnostic Automation Business Overview
- 7.17.3 Diagnostic Automation Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.17.4 Diagnostic Automation Helicobacter Pylori Antigen Test Product Portfolio
- 7.17.5 Diagnostic Automation Recent Developments
- 7.18 DRG Diagnostics
- 7.18.1 DRG Diagnostics Company Information
- 7.18.2 DRG Diagnostics Business Overview
- 7.18.3 DRG Diagnostics Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.18.4 DRG Diagnostics Helicobacter Pylori Antigen Test Product Portfolio
- 7.18.5 DRG Diagnostics Recent Developments
- 7.19 Epitope Diagnostics
- 7.19.1 Epitope Diagnostics Company Information
- 7.19.2 Epitope Diagnostics Business Overview
- 7.19.3 Epitope Diagnostics Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.19.4 Epitope Diagnostics Helicobacter Pylori Antigen Test Product Portfolio
- 7.19.5 Epitope Diagnostics Recent Developments
- 7.20 SD Biosensor
- 7.20.1 SD Biosensor Company Information
- 7.20.2 SD Biosensor Business Overview
- 7.20.3 SD Biosensor Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.20.4 SD Biosensor Helicobacter Pylori Antigen Test Product Portfolio
- 7.20.5 SD Biosensor Recent Developments
- 7.21 DiaSorin
- 7.21.1 DiaSorin Company Information
- 7.21.2 DiaSorin Business Overview
- 7.21.3 DiaSorin Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.21.4 DiaSorin Helicobacter Pylori Antigen Test Product Portfolio
- 7.21.5 DiaSorin Recent Developments
- 7.22 QuidelOrtho
- 7.22.1 QuidelOrtho Company Information
- 7.22.2 QuidelOrtho Business Overview
- 7.22.3 QuidelOrtho Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 7.22.4 QuidelOrtho Helicobacter Pylori Antigen Test Product Portfolio
- 7.22.5 QuidelOrtho Recent Developments
8 North America
- 8.1 North America Helicobacter Pylori Antigen Test Revenue (2021-2032)
- 8.2 North America Helicobacter Pylori Antigen Test Revenue by Type (2021-2032)
- 8.2.1 North America Helicobacter Pylori Antigen Test Revenue by Type (2021-2026)
- 8.2.2 North America Helicobacter Pylori Antigen Test Revenue by Type (2027-2032)
- 8.3 North America Helicobacter Pylori Antigen Test Revenue Share by Type (2021-2032)
- 8.4 North America Helicobacter Pylori Antigen Test Revenue by Application (2021-2032)
- 8.4.1 North America Helicobacter Pylori Antigen Test Revenue by Application (2021-2026)
- 8.4.2 North America Helicobacter Pylori Antigen Test Revenue by Application (2027-2032)
- 8.5 North America Helicobacter Pylori Antigen Test Revenue Share by Application (2021-2032)
- 8.6 North America Helicobacter Pylori Antigen Test Revenue by Country
- 8.6.1 North America Helicobacter Pylori Antigen Test Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Helicobacter Pylori Antigen Test Revenue by Country (2021-2026)
- 8.6.3 North America Helicobacter Pylori Antigen Test Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Helicobacter Pylori Antigen Test Revenue (2021-2032)
- 9.2 Europe Helicobacter Pylori Antigen Test Revenue by Type (2021-2032)
- 9.2.1 Europe Helicobacter Pylori Antigen Test Revenue by Type (2021-2026)
- 9.2.2 Europe Helicobacter Pylori Antigen Test Revenue by Type (2027-2032)
- 9.3 Europe Helicobacter Pylori Antigen Test Revenue Share by Type (2021-2032)
- 9.4 Europe Helicobacter Pylori Antigen Test Revenue by Application (2021-2032)
- 9.4.1 Europe Helicobacter Pylori Antigen Test Revenue by Application (2021-2026)
- 9.4.2 Europe Helicobacter Pylori Antigen Test Revenue by Application (2027-2032)
- 9.5 Europe Helicobacter Pylori Antigen Test Revenue Share by Application (2021-2032)
- 9.6 Europe Helicobacter Pylori Antigen Test Revenue by Country
- 9.6.1 Europe Helicobacter Pylori Antigen Test Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Helicobacter Pylori Antigen Test Revenue by Country (2021-2026)
- 9.6.3 Europe Helicobacter Pylori Antigen Test Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Helicobacter Pylori Antigen Test Revenue (2021-2032)
- 10.2 China Helicobacter Pylori Antigen Test Revenue by Type (2021-2032)
- 10.2.1 China Helicobacter Pylori Antigen Test Revenue by Type (2021-2026)
- 10.2.2 China Helicobacter Pylori Antigen Test Revenue by Type (2027-2032)
- 10.3 China Helicobacter Pylori Antigen Test Revenue Share by Type (2021-2032)
- 10.4 China Helicobacter Pylori Antigen Test Revenue by Application (2021-2032)
- 10.4.1 China Helicobacter Pylori Antigen Test Revenue by Application (2021-2026)
- 10.4.2 China Helicobacter Pylori Antigen Test Revenue by Application (2027-2032)
- 10.5 China Helicobacter Pylori Antigen Test Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Helicobacter Pylori Antigen Test Revenue (2021-2032)
- 11.2 Asia Helicobacter Pylori Antigen Test Revenue by Type (2021-2032)
- 11.2.1 Asia Helicobacter Pylori Antigen Test Revenue by Type (2021-2026)
- 11.2.2 Asia Helicobacter Pylori Antigen Test Revenue by Type (2027-2032)
- 11.3 Asia Helicobacter Pylori Antigen Test Revenue Share by Type (2021-2032)
- 11.4 Asia Helicobacter Pylori Antigen Test Revenue by Application (2021-2032)
- 11.4.1 Asia Helicobacter Pylori Antigen Test Revenue by Application (2021-2026)
- 11.4.2 Asia Helicobacter Pylori Antigen Test Revenue by Application (2027-2032)
- 11.5 Asia Helicobacter Pylori Antigen Test Revenue Share by Application (2021-2032)
- 11.6 Asia Helicobacter Pylori Antigen Test Revenue by Country
- 11.6.1 Asia Helicobacter Pylori Antigen Test Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Helicobacter Pylori Antigen Test Revenue by Country (2021-2026)
- 11.6.3 Asia Helicobacter Pylori Antigen Test Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Helicobacter Pylori Antigen Test Revenue (2021-2032)
- 12.2 SAMEA Helicobacter Pylori Antigen Test Revenue by Type (2021-2032)
- 12.2.1 SAMEA Helicobacter Pylori Antigen Test Revenue by Type (2021-2026)
- 12.2.2 SAMEA Helicobacter Pylori Antigen Test Revenue by Type (2027-2032)
- 12.3 SAMEA Helicobacter Pylori Antigen Test Revenue Share by Type (2021-2032)
- 12.4 SAMEA Helicobacter Pylori Antigen Test Revenue by Application (2021-2032)
- 12.4.1 SAMEA Helicobacter Pylori Antigen Test Revenue by Application (2021-2026)
- 12.4.2 SAMEA Helicobacter Pylori Antigen Test Revenue by Application (2027-2032)
- 12.5 SAMEA Helicobacter Pylori Antigen Test Revenue Share by Application (2021-2032)
- 12.6 SAMEA Helicobacter Pylori Antigen Test Revenue by Country
- 12.6.1 SAMEA Helicobacter Pylori Antigen Test Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Helicobacter Pylori Antigen Test Revenue by Country (2021-2026)
- 12.6.3 SAMEA Helicobacter Pylori Antigen Test Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst